Sugi Predict

Sugi Predict / Compounds / Dimethylamine

Dimethylamine

Dimethylamine

SCHEMBL5833299

CCOc1ccc(Br)c2c1CCCC2.CNC

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 3/20 0.35
▸ TP53 P04637 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ADRB1 P08588 3/20 0.35
▸ ADRB2 P07550 3/20 0.35
▸ RXRA P19793 2/20 0.35
▸ RXRB P28702 2/20 0.35
▸ RXRG P48443 2/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ ADRB3 P13945 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5441946 0.81 KDM4E (0.45) KDM4EALDH1A1HDAC1HDAC6POLB
SCHEMBL29320840 0.78 KDM4E (0.39) KDM4EALDH1A1HDAC1HDAC6LMNA
SCHEMBL5449557 0.78 KDM4E (0.45) KDM4EALDH1A1POLBLMNAHPGD
Dimethylamine SCHEMBL5833595 0.78 ALDH1A1 (0.38) KDM4EALDH1A1POLBLMNAHPGD
SCHEMBL5833297 0.75 HTR7 (0.54) KDM4EALDH1A1CYP1A2CYP2D6SMN1; SMN2
SCHEMBL19249309 0.75 RXRG (0.51) KDM4EALDH1A1POLBLMNAHPGD
SCHEMBL6169404 0.74 KDM4E (0.53) KDM4EALDH1A1HDAC1HDAC6LMNA
SCHEMBL30465797 0.74 KDM4E (0.53) KDM4EALDH1A1HDAC1HDAC6LMNA
SCHEMBL12251522 0.73 RXRG (0.53) KDM4EALDH1A1LMNATP53MAPT
SCHEMBL5833502 0.72 RXRA (0.49) ALDH1A1MAPTTDP1L3MBTL1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7012078-B2 2-aminopyridines containing fused ring substituents PFIZER INC. (US) 2006-03-14 — — US disclosed
EP-1007520-B1 2-AMINOPYRIDINES CONTAINING FUSED RING SUBSTITUENTS AS NOS INHIBITORS PFIZER PROD INC (US) 2003-08-27 — — EP disclosed
US-20030149017-A1 2-Aminopyridines containing fused ring substituents PFIZER INC. 2003-08-07 — — US disclosed
US-20010049379-A1 2-aminopyridines containing fused ring substituents LOWE JOHN ADAMS (US) 2001-12-06 — — US disclosed
EP-1007520-A1 2-AMINOPYRIDINES CONTAINING FUSED RING SUBSTITUENTS AS NOS INHIBITORS Pfizer Products Inc. (US) 2000-06-14 — — EP disclosed
WO-1999010339-A1 2-AMINOPYRIDINES CONTAINING FUSED RING SUBSTITUENTS AS NOS INHIBITORS PFIZER PRODUCTS INC. (US) 1999-03-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149017-A1 2-Aminopyridines containing fused ring substituents NOS2, NOS1, NOS3 KDM4E 1934/4885ALDH1A1 325/4885HDAC1 715/4885
US-20010049379-A1 2-aminopyridines containing fused ring substituents NOS2, NOS1, NOS3 KDM4E 1934/4885ALDH1A1 325/4885HDAC1 715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.